Stroke Reperfusion Therapy Following Dabigatran Reversal With Idarucizumab in a National Cohort

In the article “Stroke Reperfusion Therapy Following Dabigatran Reversal With Idarucizumab in a National Cohort” by Barber et al.,1 the first sentence in the Methods section should denote this study as providing Class III evidence. The authors regret the error.

Read article at journal's website

Related Articles

Responses

Your email address will not be published. Required fields are marked *